MSP Recovery Price to Sales Ratio 2020-2024 | MSPR

Historical PS ratio values for MSP Recovery (MSPR) over the last 10 years. The current P/S ratio for MSP Recovery as of February 20, 2025 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
MSP Recovery P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2025-02-21 2.51 0.15
2024-09-30 0.15 $16.76 0.01
2024-03-31 0.69 $25.76 0.03
2023-12-31 2.27 $43.94 0.05
2023-09-30 0.21 $56.05 0.00
2023-06-30 0.33 $55.68 0.01
2023-03-31 0.85 $119.81 0.01
2022-12-31 1.60 $336.04 0.00
2024-06-30 0.46 $321.89 0.00
2022-09-30 1.20 $321.39 0.00
2022-06-30 2.14 $244.40 0.01
2022-03-31 10.26 0 0.00
2021-12-31 9.96 0 0.00
2021-09-30 9.91 0 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.016B $0.008B
MSP Recovery LLC. is a medicare, medicaid, commercial and secondary payer reimbursement recovery leader. It provides the healthcare industry with comprehensive compliance solutions. MSP Recovery LLC., formerly known as Lionheart Acquisition Corporation II, is based in CORAL GABLES, Fla.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $37.136B 54.72
Hims & Hers Health (HIMS) United States $14.509B 368.94
Tempus AI (TEM) United States $12.079B 0.00
Inspire Medical Systems (INSP) United States $5.293B 103.12
IRhythm Technologies (IRTC) United States $3.526B 0.00
Privia Health (PRVA) United States $2.957B 246.40
Enovis (ENOV) United States $2.496B 16.63
Clover Health Investments (CLOV) United States $2.250B 0.00
Azenta (AZTA) United States $2.046B 95.28
Omnicell (OMCL) United States $1.836B 40.05
Schrodinger (SDGR) United States $1.749B 0.00
Phreesia (PHR) United States $1.654B 0.00
10x Genomics (TXG) United States $1.414B 0.00
Butterfly Network (BFLY) United States $0.944B 0.00
Talkspace (TALK) United States $0.556B 329.00
Fulgent Genetics (FLGT) United States $0.509B 0.00
Standard BioTools (LAB) United States $0.503B 0.00
TruBridge (TBRG) United States $0.417B 121.39
Nyxoah SA (NYXH) Belgium $0.354B 0.00
Pulmonx (LUNG) United States $0.347B 0.00
Health Catalyst (HCAT) United States $0.328B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.277B 0.00
American Well (AMWL) United States $0.188B 0.00
EUDA Health Holdings (EUDA) Singapore $0.101B 0.00
MDxHealth SA (MDXH) Belgium $0.088B 0.00
P3 Health Partners (PIII) United States $0.078B 0.00
111 (YI) China $0.070B 0.00
CareCloud (CCLD) United States $0.061B 0.00
HeartBeam (BEAT) United States $0.056B 0.00
Outset Medical (OM) United States $0.052B 0.00
Zepp Health (ZEPP) China $0.045B 0.00
SHL Telemedicine (SHLT) Israel $0.038B 0.00
Zhongchao (ZCMD) China $0.036B 0.00
Movano (MOVE) United States $0.033B 0.00
Bullfrog AI Holdings (BFRG) United States $0.028B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.021B 0.00
Streamline Health Solutions (STRM) United States $0.015B 0.00
Precipio (PRPO) United States $0.014B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Tivic Health Systems (TIVC) United States $0.005B 0.00
Syra Health (SYRA) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00